AGP Picks
View all

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on May 6, 2026

Axes Physical Therapy Opens New Location in Columbia, MO Bringing Award-Winning Care to Mid-Missouri
Neckwise Marks First Anniversary of Fort Myers Location, Expanding Access to Precision Upper Cervical Chiropractic Care
Zionsville Facial Plastic Surgeon Discusses Advanced Non-Surgical Treatments
Women’s Hormonal Health Takes Center Stage in Monaco - Medi-Gyn Transforms Women’s Hormonal #Longevity #HormoneHealth
AVer Announces the MD331UI Medical Grade PTZ Camera to Elevate Virtual Rounding and Remote Patient Care
Aram Group PJSC and Prepaire Labs Launch Strategic Alliance to Build the UAE’s Biological Infrastructure Network
Maternal Sleep Crisis: New National Surveys Show 86% of U.S. Mothers Lose Sleep Every Night
Ballad Health Academy welcomes second class of students amid new program offerings and expansions
The Algorithmic Gatekeeper: Balancing AI Speed with Human Empathy in International Private Medical Insurance
Image Analysis Group × HeartcoR Solutions – Press Release
InsuLeaf Claims Evaluated: The Safer & More Effective than GLP-1 Drugs, Natural Leak Peak Formula
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2026 Financial Results on May 8, 2026
RevitalVision, a Digital Therapeutic, Demonstrates Efficacy and Safety in Infantile Nystagmus
Mast Group wins Medilink Partnership Award for pioneering role in bowel cancer screening
Behavidence Launches Clinical Partnership Program to Advance Mental Health RTM with Passive Digital Biomarkers
Memora Claims Evaluated: New Memory Health Report Examines Advanced Brain Health Supplement for Preventing Cognitive Decline
ERIN Launches Free AI Employee Referral Platform That Goes Live in Minutes
SecureIQLab Opens Post-Quantum Validation of Cloud-Native Firewalls
Totus Medicines Presents Early Phase 1b Clinical Data Demonstrating 100% Disease Control Rate and Class-Leading Safety for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER2- Breast Cancer at ESMO Breast Cancer Annual Congress 2026
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.